EcoDrugPlus

60s Ribosomal Protein L10

Ensembl ID : ENSDCDG00000018336
Gene Symbol: LOC114798253
3 Cross references
408 Possible Orthologues:

60s Ribosomal Protein L17

Ensembl ID : ENSDCDG00000011297
Gene Symbol: LOC114774610
3 Cross references
320 Possible Orthologues:

60s Ribosomal Protein L17

Ensembl ID : ENSDCDG00000001503
Gene Symbol: LOC114786180
3 Cross references
320 Possible Orthologues:

60s Ribosomal Protein L21

Ensembl ID : ENSDCDG00000008858
Gene Symbol: LOC114777748
3 Cross references
755 Possible Orthologues:

60s Ribosomal Protein L22-Like

Ensembl ID : ENSDCDG00000029928
Gene Symbol: LOC114797629
2 Cross references
324 Possible Orthologues:

60s Ribosomal Protein L23a

Ensembl ID : ENSDCDG00000010822
Gene Symbol: LOC114780408
3 Cross references
817 Possible Orthologues:

60s Ribosomal Protein L26

Ensembl ID : ENSDCDG00000014848
Gene Symbol: LOC114782470
3 Cross references
476 Possible Orthologues:

60s Ribosomal Protein L26

Ensembl ID : ENSDCDG00000013279
Gene Symbol: LOC114782476
3 Cross references
476 Possible Orthologues:

60s Ribosomal Protein L3

Ensembl ID : ENSDCDG00000021526
Gene Symbol: LOC114793845
3 Cross references
338 Possible Orthologues:

60s Ribosomal Protein L30-Like

Ensembl ID : ENSDCDG00000022893
Gene Symbol: LOC114770355
3 Cross references
311 Possible Orthologues:

A-Raf Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSDCDG00000031008
Gene Symbol: ARAF
3 Cross references
191 Possible Orthologues:

Abl Proto-Oncogene 1, Non-Receptor Tyrosine Kinase

Ensembl ID : ENSDCDG00000003881
Gene Symbol: ABL1
3 Cross references
202 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).